Medis ehf.

About Medis ehf.

Medis is a leader in pharmaceutical development and out licensing, offering a broad portfolio of quality pharmaceutical products and comprehensive registration dossiers and intellectual property since 1985. Medis is a powerful partner with a proven track record in securing regulatory approval prior to patent expiries, and has obtained marketing authorizations in over 140 countries to date. We out-license products from the pipeline of our parent company, Teva. Medis ehf is 100% owned by Teva Pharmaceutical Industries Ltd (NYSE, TASE: TEVA).

We offer:
•Dossiers with product supply for generic products for all major therapeutic categories
•Full launch coordination to ensure customers timely Day-1 launches to market
•High quality generic products and registration dossiers according to current EU standards (CTD)
•Extensive generic portfolio with more than 150 dossiers and around 800 available licenses
•Single-point-of-contact...

Certifications
  • IS
  • 2015
    On CPHI since
  • 2
    Certificates
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from Medis ehf. (1)

  • Out-licensing

    Product Out-licensing

    Medis is an established provider of dossiers and products in all areas of the world with launches and marketing authorizations in over 140 countries to date.

Medis ehf. Resources (1)